While VHL loss is the key initiating event, ccRCC progression is driven by subsequent loss of epigenetic regulators SETD2, PBRM1, and BAP1, which result in a profoundly disrupted epigenome leading to aberrant gene expression and deregulated cell growth control [5–7]. Here, BAP1 is linked to nonpapillary renal cell carcinoma.